|Bid||200.00 x 800|
|Ask||211.00 x 1000|
|Day's Range||206.36 - 210.70|
|52 Week Range||154.37 - 224.95|
|Beta (5Y Monthly)||0.80|
|PE Ratio (TTM)||32.28|
|Earnings Date||Jan 31, 2022|
|Forward Dividend & Yield||4.60 (2.19%)|
|Ex-Dividend Date||Dec 30, 2021|
|1y Target Est||229.73|
Subscribe to Yahoo Finance Plus to view Fair Value for ARELearn more
In this segment from Motley Fool Live, recorded on Jan. 6, Fool contributors Jason Hall and Marc Rapport discuss the strong tailwind pushing Alexandria Real Estate Equities (NYSE: ARE) this year. Jason Hall: What is ARE, what do they do? Marc Rapport: They own and operate in net lease out lab space basically.
In 2020, the property was selected to be the site of a large facility meant to produce injection devices for the mass delivery of vaccines. But that project remains in limbo.
The property features 70,132 square feet of leasable space plus room for up to 1 million square feet of additional development.